Pharmaceutical firm AstraZeneca has said it will invest £300m into UK drugs development in what the prime minister has described as a "major vote of confidence" in the country. It comes seven months ...

AstraZeneca (LSE:AZN) and Daiichi Sankyo reported DESTINY-Lung04 Phase III results showing ENHERTU delayed disease progression in HER2-mutant advanced NSCLC versus standard therapy. Long-term ...

AstraZeneca PLC is a leading global pharmaceutical company with strong growth in oncology, diversified revenues, and a robust pipeline. AZN's financials show improving margins, rising EPS, and ...

AstraZeneca remains a long-term buy, driven by a diversified portfolio, robust R&D, and strong FCF, despite a current valuation that is slightly stretched. AZN's 2025 results showed 8% revenue and 11% ...

AstraZeneca posted second-quarter earnings that topped analyst expectations on Monday, as its cancer drug franchise delivered the growth needed to keep the company's decade-long revenue strategy ...

On September 8, 2026, CNBC reported that AstraZeneca PLC (NYSE:AZN) released full results from two successful late-stage trials of tozorakimab, an experimental drug for chronic obstructive pulmonary ...

AstraZeneca AZN is scheduled to report fourth-quarter and full-year 2025 results on Feb. 10, before the opening bell. In the last reported quarter, the company delivered an earnings surprise of 4.39% ...

AstraZeneca, the U.K.-Swedish pharmaceutical giant, on Tuesday announced a plan to invest some $50 billion in the U.S. in a move hailed by the Trump administration - though much of what it is ...

AstraZeneca plc is moving while everyone’s distracted by memes and microcaps. Is this pharma giant a slept-on power play or just overhyped healthcare wallpaper? Real talk, here’s what you need to know ...

Etcamah is the second oral “SERD” to recently fall short in first-line breast cancer, following a similar setback from Roche ...

AstraZeneca just quietly flexed on the market. Is this pharma giant a low-key must-have in your portfolio or just boomer stock cosplay? Real talk, here is what the numbers and hype actually say. The ...